Daxor Corporation’s BVA Technology Proven to Reduce Hospital Readmissions and Enhance Survival Rates in Heart Failure Patients

Daxor Corporation’s BVA Technology Proven to Reduce Hospital Readmissions and Enhance Survival Rates in Heart Failure Patients

Three Studies Validate BVA-Guided Care Significantly Cuts Hospital Readmissions and Boosts Survival in High-Cost Heart Failure…

Continue Reading
American Heart Association Launches Virtual Care Program to Reduce Heart Failure Readmissions

American Heart Association Launches Virtual Care Program to Reduce Heart Failure Readmissions

What You Should Know: – With chronic disease rates rising and nearly one in four heart…

Continue Reading
Coaches help to reduce heart failure re-admissions

Coaches help to reduce heart failure re-admissions

Professor James Calvin from Western University’s Department of Medicine presents his important research comparing two innovative…

Continue Reading
How remote patient care helped cut heart failure readmissions

How remote patient care helped cut heart failure readmissions

Chronic diseases place a significant burden on the U.S. healthcare system, making effective chronic disease…

Continue Reading
Incidence and predictors of unplanned 30-day hospital readmissions among heart failure patients in Ethiopia: a 5-year retrospective cohort study

Incidence and predictors of unplanned 30-day hospital readmissions among heart failure patients in Ethiopia: a 5-year retrospective cohort study

Labrosciano, C. et al. Frequency, trends and institutional variation in 30-day all-cause mortality and unplanned readmissions…

Continue Reading
Cost of hospital readmissions ‘disproportionally high’: study

Cost of hospital readmissions ‘disproportionally high’: study

A recent study from the University of Queensland highlights the potentially preventable cost of unexpected hospital…

Continue Reading